ImmunityBio, Inc. (IBRX)
6.07
-0.60
(-9.00%)
USD |
NASDAQ |
Nov 12, 16:00
6.10
+0.03
(+0.49%)
After-Hours: 06:39
ImmunityBio Price : 6.07 for Nov. 12, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 12, 2026 | 6.45 | 6.50 | 6.00 | 6.07 | 21.02M |
| Nov 11, 2026 | 6.80 | 6.847 | 6.51 | 6.67 | 11.97M |
| Nov 10, 2026 | 6.98 | 7.27 | 6.61 | 6.745 | 20.04M |
| Nov 09, 2026 | 7.22 | 7.345 | 6.36 | 7.11 | 44.87M |
| Nov 06, 2026 | 8.17 | 8.69 | 7.880 | 8.635 | 9.274M |
| Nov 05, 2026 | 8.78 | 8.79 | 8.00 | 8.01 | 12.56M |
| Nov 04, 2026 | 8.42 | 8.95 | 8.205 | 8.93 | 9.778M |
| Nov 03, 2026 | 8.00 | 8.43 | 7.97 | 8.29 | 6.190M |
| Nov 02, 2026 | 8.32 | 8.39 | 7.93 | 7.95 | 9.063M |
| Oct 30, 2026 | 8.48 | 8.725 | 8.122 | 8.29 | 8.960M |
| Oct 29, 2026 | 8.75 | 8.935 | 8.560 | 8.74 | 7.148M |
| Oct 28, 2026 | 8.61 | 8.83 | 8.48 | 8.81 | 7.166M |
| Oct 27, 2026 | 7.82 | 8.685 | 7.765 | 8.63 | 10.51M |
| Oct 26, 2026 | 8.23 | 8.28 | 7.75 | 7.81 | 11.05M |
| Oct 23, 2026 | 8.21 | 8.355 | 8.05 | 8.22 | 5.944M |
| Oct 22, 2026 | 8.53 | 8.84 | 8.02 | 8.31 | 12.74M |
| Oct 21, 2026 | 8.79 | 8.99 | 8.32 | 8.64 | 11.51M |
| Oct 20, 2026 | 8.31 | 8.90 | 8.11 | 8.77 | 14.11M |
| Oct 19, 2026 | 9.19 | 9.697 | 8.305 | 8.42 | 19.57M |
| Oct 16, 2026 | 10.02 | 10.02 | 9.02 | 9.18 | 21.51M |
| Oct 15, 2026 | 10.20 | 10.50 | 9.815 | 10.00 | 20.01M |
| Oct 14, 2026 | 9.69 | 10.46 | 9.35 | 9.91 | 30.23M |
| Oct 13, 2026 | 10.00 | 10.06 | 9.56 | 9.80 | 11.60M |
| Oct 12, 2026 | 10.59 | 10.62 | 10.05 | 10.12 | 11.06M |
| Oct 09, 2026 | 9.95 | 10.80 | 9.87 | 10.51 | 18.66M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Moderna, Inc. | 231.35 |
| Sarepta Therapeutics, Inc. | 16.01 |
| Arrowhead Pharmaceuticals, Inc. | 47.15 |
| Oncolytics Biotech, Inc. | 0.372 |
| Sangamo Therapeutics, Inc. | 0.11 |
Price Related Metrics
| PS Ratio | 34.30 |
| PEG Ratio | -0.0365 |
| Earnings Yield | -17.67% |
| Market Cap | 6.457B |
| PEGY Ratio | -0.0365 |